A new study underway at St. David’s Surgical Hospital could help men recover faster and live a better quality of life after ...
BERLIN — For men with high-risk biochemically recurrent prostate cancer, adding enzalutamide (Xtandi) to standard androgen ...
Men with suspected prostate cancer will be able to get a diagnosis on the NHS within a day, under “game-changing” new trials.
A new branch of a national cancer charity has opened in the grounds of a town's hospital. The Maggie's Centre will offer ...
Rung the Bell!” Ashley Biden, the former president’s daughter, wrote in an Instagram post with a video of her father clanging ...
RUMC hosted the screening and education program at the local JCC, bringing medical professionals together with the former All ...
Sunak is an ambassador for Prostate Cancer Research, which is publishing a report on the costs and benefits of a targeted ...
A charity concert has raised an incredible £20,000 for the prostate cancer research fund at Southend Hospital. The Music of ...
MedPage Today on MSN
OS Win for Enzalutamide in Prostate Cancer at High Risk for Biochemical Recurrence
BERLIN -- Combining enzalutamide (Xtandi) with androgen deprivation therapy (ADT) significantly improved overall survival (OS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback